What the superinvestors bought and sold in 2025 Q1
2025 Q1
136 of 137 filedThe quarter at a glance
78 of 136 managers were net sellers. Setting price aside, they took $9.5B out, led by Financials (−$10.4B), while adding to Energy (+$2.6B). FLUT was the most widely bought stock (13 bought, 2 sold); GOOGL / GOOG the most widely sold (28 sold, 10 bought).
Net buyers
52 of 136 managers
78 sold more than they bought · 6 about even
Net bought
−$9.5B
Price moves taken out; prices alone moved the book −$27B.
Positions opened
630
729 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter
−3.8%
SPY −4.6%,
0.7 pts ahead.
Price only.
Most bought and sold
Ranked by how many managers bought minus how many sold, with price moves taken out. Open a stock to see who.
Most bought
-
1 FLUT Flutter Entmt PLC 13 bought · 2 sold +$1.3B
Bought by
- Ako Capital opened 7.4% of book
- John Armitage - Egerton Capital (UK) added 5.6% → 5.6%
- Stephen Mandel - Lone Pine Capital added 3.7% → 4.2%
- Dan Loeb - Third Point added 3.0% → 3.3%
- Senator Investment Group added 1.6% → 3.0%
- Stanley Druckenmiller - Duquesne Family Office added 0.13% → 2.7%
- Brad Gerstner - Altimeter Capital Management added 1.8% → 2.5%
- Ben Jacobs - Anomaly Capital Management opened 1.9% of book
and 5 more
Sold by
- Tom Bancroft - Makaira Partners cut 8.7% → 7.9%
- Ryan Packard - Hiddenite Capital Partners closed was 1.5%
-
2 TSM Taiwan Semiconductor Mfg Ltd 18 bought · 9 sold +$273M
Bought by
- Grant Wonders - Voyager Global Management added 10.8% → 15.0%
- Ram Parameswaran - Octahedron Capital Management opened 6.6% of book
- Robert Karr - Joho Capital opened 4.8% of book
- Lee Ainslie - Maverick Capital added 4.4% → 4.3%
- Eric Mandelblatt - Soroban Capital Partners added 2.5% → 3.5%
- Stanley Druckenmiller - Duquesne Family Office added 0.57% → 3.2%
- Chase Coleman - Tiger Global Management added 2.7% → 2.6%
- Andreas Halvorsen - Viking Global Investors added 2.6% → 2.6%
and 10 more
Sold by
- Glen Kacher - Light Street Capital Management cut 12.4% → 14.8%
- Philippe Laffont - Coatue Management cut 6.6% → 5.8%
- Brad Gerstner - Altimeter Capital Management closed was 1.8%
- Nehal Chopra - Ratan Capital Management cut 1.5% → 1.2%
- Ron Baron - Bamco Inc. (Baron Capital) cut 0.45% → 0.31%
- John Rogers - Ariel Investments cut 0.17% → 0.06%
- George Soros - Soros Fund Management closed was 0.12%
- Francois Rochon - Giverny Capital cut 0.11% → 0.07%
and 1 more
-
3 PRMB Primo Brands Corporation 8 bought · 0 sold +$503M
Bought by
- Senator Investment Group added 1.3% → 4.1%
- Dan Sundheim - D1 Capital Partners opened 2.8% of book
- Dan Loeb - Third Point added 0.99% → 1.5%
- Lee Ainslie - Maverick Capital opened 1.2% of book
- Andreas Halvorsen - Viking Global Investors opened 0.57% of book
- George Soros - Soros Fund Management opened 0.26% of book
- Davidson Kempner Capital Management opened 0.11% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.02% of book
Sold by
No manager sold.
-
4 NVDA Nvidia Corporation 16 bought · 9 sold +$528M
Bought by
- Ram Parameswaran - Octahedron Capital Management added 5.4% → 6.7%
- Lee Ainslie - Maverick Capital added 5.1% → 5.4%
- Chase Coleman - Tiger Global Management added 4.9% → 4.5%
- Gavin Baker - Atreides Management opened 3.6% of book
- Estuary Capital Management opened 2.5% of book
- Dan Loeb - Third Point opened 2.4% of book
- Andreas Halvorsen - Viking Global Investors added 0.88% → 2.3%
- Senator Investment Group added 1.3% → 2.1%
and 8 more
Sold by
- Brad Gerstner - Altimeter Capital Management cut 19.0% → 15.6%
- Nehal Chopra - Ratan Capital Management cut 17.2% → 10.3%
- Glen Kacher - Light Street Capital Management cut 10.3% → 9.7%
- Mala Gaonkar - Surgocap Partners closed was 7.2%
- Alex Sacerdote - Whale Rock Capital Management cut 4.8% → 3.5%
- Philippe Laffont - Coatue Management cut 4.5% → 4.1%
- David Tepper - Appaloosa cut 1.4% → 0.39%
- Murray Stahl - Horizon Kinetics Asset Management cut 0.04% → 0.03%
and 1 more
-
5 SGI Somnigroup International Inc. 8 bought · 1 sold +$515M
Bought by
- David Abrams - Abrams Capital Management added 3.3% → 6.2%
- Chris James - Meritage Group opened 3.1% of book
- Davidson Kempner Capital Management opened 1.3% of book
- Dan Sundheim - D1 Capital Partners opened 1.2% of book
- Seth Klarman - Baupost Group opened 1.2% of book
- Farallon Capital Management opened 0.44% of book
- George Soros - Soros Fund Management opened 0.25% of book
- Senator Investment Group opened 0.02% of book
Sold by
- Lee Ainslie - Maverick Capital cut 1.3% → 1.1%
-
6 SNPS Synopsys Inc. 5 bought · 0 sold +$108M
Bought by
- Dan Sundheim - D1 Capital Partners added 2.0% → 2.2%
- Gavin Baker - Atreides Management opened 2.0% of book
- Torray Investment Partners added 1.1% → 1.2%
- Glen Kacher - Light Street Capital Management added 0.04% → 0.44%
- Davidson Kempner Capital Management opened 0.26% of book
Sold by
No manager sold.
-
7 AMAT Applied Materials, Inc. 5 bought · 0 sold +$48M
Bought by
- Christopher Davis - Davis Selected Advisers added 4.5% → 4.2%
- Rule One Partners opened 0.85% of book
- Ben Hoskin - Value Aligned Research Advisors opened 0.60% of book
- Dan Sundheim - D1 Capital Partners added 0.49% → 0.46%
- George Soros - Soros Fund Management opened 0.11% of book
Sold by
No manager sold.
-
8 PSX Phillips 66 4 bought · 0 sold +$2.1B
Bought by
- Paul Singer - Elliott Investment Management added 0.53% → 12.8%
- Bill Nygren / Oakmark - Harris Associates L P added 1.8% → 2.9%
- Murphy Pohlad - Murphy Pohlad Asset Management opened 0.09% of book
- Mairs & Power added <0.01% → 0.01%
Sold by
No manager sold.
-
9 EFX Equifax Inc. 6 bought · 2 sold +$269M
Bought by
- Wallace Weitz - Weitz Investment Management added 2.5% → 2.7%
- Chris James - Meritage Group opened 2.7% of book
- Ako Capital added 2.6% → 2.4%
- Bill Nygren / Oakmark - Harris Associates L P added 1.2% → 1.9%
- Robert Olstein - Olstein Capital Management added 0.58% → 0.67%
- Ron Baron - Bamco Inc. (Baron Capital) added <0.01% → <0.01%
Sold by
- Jensen Investment Management cut 2.8% → 2.9%
- Terry Smith - Fundsmith cut 0.39% → 0.26%
-
10 TEVA Teva Pharmaceutical Inds Ltd 7 bought · 3 sold +$261M
Bought by
- Stanley Druckenmiller - Duquesne Family Office added 5.3% → 7.5%
- Glenview Capital Management added 4.7% → 5.6%
- Harry Burn - Sound Shore Management added 3.5% → 2.9%
- David Witzke - Avidity Partners Management opened 1.4% of book
- Andreas Halvorsen - Viking Global Investors added 0.46% → 0.49%
- David Einhorn - DME Capital Management added 0.53% → 0.44%
- Lee Ainslie - Maverick Capital added <0.01% → <0.01%
Sold by
- Bill Miller - Miller Value Partners closed was 0.10%
- Samantha Mclemore - Patient Capital Management closed was 0.10%
- Cathie Wood - Ark Investment Management cut 0.02% → 0.01%
Not counted as buying: 173 IPOs, spin-offs and new listings.
Most sold
-
1 GOOGL / GOOG Alphabet 10 bought · 28 sold −$3.2B
Sold by
- Li Lu - Himalaya Capital Management cut 39.1% → 35.1%
- Andrew Steginsky - Steginsky Capital cut 27.1% → 22.5%
- Triple Frond Partners cut 19.9% → 13.7%
- Eric Mandelblatt - Soroban Capital Partners cut 17.4% → 12.1%
- Bill Ackman - Pershing Square cut 17.4% → 14.0%
- First Pacific Advisors cut 12.2% → 10.3%
- Thomas Russo - Gardner Russo & Quinn cut 12.2% → 9.0%
- Chris Hohn - Tci Fund Management cut 10.1% → 6.4%
and 20 more
Bought by
- Grant Wonders - Voyager Global Management added 20.2% → 20.0%
- Ram Parameswaran - Octahedron Capital Management added 9.9% → 10.1%
- Seth Klarman - Baupost Group added 7.9% → 9.3%
- Alex Sacerdote - Whale Rock Capital Management added 3.2% → 4.7%
- David Tepper - Appaloosa added 5.5% → 3.7%
- John Armitage - Egerton Capital (UK) added 3.3% → 3.0%
- Sarah Ketterer - Causeway Capital Management added 2.6% → 2.3%
- Duan Yongping - H&H International Investment opened 1.4% of book
and 2 more
-
2 BRK.B / BRK.A Berkshire Hathaway 1 bought · 17 sold −$183M
Sold by
- Norbert Lou - Punch Card Management cut 75.4% → 53.4%
- Christopher Bloomstran - Semper Augustus Investments Group cut 33.9% → 35.5%
- Gates Foundation Trust cut 21.2% → 21.9%
- Thomas Russo - Gardner Russo & Quinn cut 21.0% → 21.9%
- Tweedy, Browne Co. cut 16.1% → 16.1%
- Steven Check - Check Capital Management cut 15.5% → 17.1%
- Josh Tarasoff - Greenlea Lane Capital Management cut 14.4% → 18.5%
- Wallace Weitz - Weitz Investment Management cut 7.6% → 8.1%
and 9 more
Bought by
- Duan Yongping - H&H International Investment opened 15.0% of book
-
3 MA Mastercard Inc. 2 bought · 14 sold −$634M
Sold by
- Chuck Akre - Akre Capital Management cut 16.9% → 17.6%
- Thomas Russo - Gardner Russo & Quinn cut 11.2% → 10.5%
- Eric Mandelblatt - Soroban Capital Partners cut 6.9% → 7.1%
- Vulcan Value Partners cut 5.8% → 5.9%
- Polen Capital Management cut 5.0% → 5.5%
- Jensen Investment Management cut 4.5% → 4.2%
- Davidson Kempner Capital Management cut 1.1% → 0.56%
- Grant Wonders - Voyager Global Management closed was 1.1%
and 6 more
Bought by
- Lewis Sanders - Sanders Capital added 0.90% → 1.2%
- Torray Investment Partners opened 0.03% of book
-
4 WFC Wells Fargo & Co. 1 bought · 11 sold −$1.7B
Sold by
- First Pacific Advisors cut 3.8% → 3.0%
- Harry Burn - Sound Shore Management cut 3.6% → 3.1%
- Richard Pzena - Pzena Investment Management cut 3.3% → 2.5%
- Dodge & Cox cut 2.9% → 2.4%
- Lee Ainslie - Maverick Capital closed was 2.7%
- Mairs & Power cut 1.6% → 1.6%
- Bill Nygren / Oakmark - Harris Associates L P cut 1.3% → 1.4%
- Don Yacktman - Yacktman Asset Management cut 0.87% → 0.15%
and 3 more
Bought by
- Senator Investment Group opened 1.9% of book
-
5 TSLA Tesla Inc. 1 bought · 11 sold −$461M
Sold by
- Ron Baron - Bamco Inc. (Baron Capital) cut 15.2% → 10.8%
- Nehal Chopra - Ratan Capital Management cut 10.8% → 4.2%
- Philippe Laffont - Coatue Management cut 3.0% → 1.9%
- Gavin Baker - Atreides Management cut 2.7% → 1.5%
- Dan Loeb - Third Point closed was 2.7%
- Brad Gerstner - Altimeter Capital Management closed was 2.6%
- Lee Ainslie - Maverick Capital closed was 0.64%
- Stanley Druckenmiller - Duquesne Family Office cut 0.41% → 0.16%
and 3 more
Bought by
- Andreas Halvorsen - Viking Global Investors opened 0.29% of book
-
6 V Visa Inc. 5 bought · 14 sold −$794M
Sold by
- Triple Frond Partners closed was 14.7%
- Chuck Akre - Akre Capital Management cut 8.9% → 10.7%
- Eric Mandelblatt - Soroban Capital Partners cut 8.6% → 7.4%
- David Rolfe - Wedgewood Partners cut 7.5% → 6.4%
- Terry Smith - Fundsmith cut 6.2% → 6.6%
- Wallace Weitz - Weitz Investment Management cut 5.7% → 6.0%
- Polen Capital Management cut 5.6% → 6.6%
- Vulcan Value Partners cut 5.3% → 5.9%
and 6 more
Bought by
- Valueact Capital - Valueact Holdings added 2.7% → 10.0%
- John Armitage - Egerton Capital (UK) added 3.2% → 3.9%
- Lewis Sanders - Sanders Capital added 0.91% → 1.7%
- Glenn Greenberg - Brave Warrior Advisors opened <0.01% of book
- Dodge & Cox added <0.01% → <0.01%
-
7 SPY Spdr S&P 500 ETF Tr 2 bought · 11 sold +$39M
Sold by
- Hillman Capital Management closed was 1.4%
- Don Yacktman - Yacktman Asset Management cut 0.26% → 0.03%
- Farallon Capital Management closed was 0.24%
- Vulcan Value Partners closed was 0.13%
- Francois Rochon - Giverny Capital cut 0.10% → 0.05%
- Samantha Mclemore - Patient Capital Management closed was 0.09%
- First Eagle Investment Management closed was 0.06%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.04% → <0.01%
and 3 more
Bought by
- Jana Partners Management added 12.4% → 15.6%
- George Soros - Soros Fund Management added 1.0% → 2.6%
-
8 FISV Fiserv, Inc. 0 bought · 8 sold −$1.7B
Sold by
- Mairs & Power cut 3.7% → 3.9%
- Torray Investment Partners cut 3.7% → 3.9%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.4% → 2.1%
- Senator Investment Group cut 1.5% → 2.1%
- Lewis Sanders - Sanders Capital cut 1.4% → 0.76%
- David Katz - Matrix Asset Advisors closed was 0.70%
- Vulcan Value Partners closed was 0.50%
- Samantha Mclemore - Patient Capital Management closed was 0.10%
Bought by
No manager bought.
-
9 PM Philip Morris Intl Inc. 2 bought · 10 sold −$1.3B
Sold by
- Dan Sundheim - D1 Capital Partners cut 7.3% → 3.7%
- Thomas Russo - Gardner Russo & Quinn cut 7.1% → 8.9%
- Stephen Mandel - Lone Pine Capital cut 5.8% → 4.1%
- Terry Smith - Fundsmith cut 5.8% → 7.8%
- Lee Ainslie - Maverick Capital cut 4.6% → 4.3%
- Stanley Druckenmiller - Duquesne Family Office cut 4.4% → 5.7%
- First Eagle Investment Management cut 2.6% → 3.0%
- Andreas Halvorsen - Viking Global Investors cut 2.0% → 1.6%
and 2 more
Bought by
- Philippe Laffont - Coatue Management opened 1.1% of book
- David Katz - Matrix Asset Advisors opened 0.02% of book
-
10 AAPL Apple Inc. 5 bought · 13 sold +$5.9B
Sold by
- Jensen Investment Management cut 7.5% → 6.9%
- Lewis Sanders - Sanders Capital cut 6.4% → 4.8%
- Polen Capital Management cut 4.2% → 1.9%
- Li Lu - Himalaya Capital Management cut 2.9% → 1.1%
- Glen Kacher - Light Street Capital Management cut 2.4% → 0.39%
- Alex Sacerdote - Whale Rock Capital Management closed was 1.7%
- Davidson Kempner Capital Management closed was 0.23%
- Francois Rochon - Giverny Capital cut 0.16% → 0.08%
and 5 more
Bought by
- Duan Yongping - H&H International Investment opened 63.3% of book
- Estuary Capital Management opened 9.3% of book
- Robert Olstein - Olstein Capital Management added 0.51% → 0.94%
- Ron Baron - Bamco Inc. (Baron Capital) added 0.20% → 0.21%
- Dodge & Cox added <0.01% → <0.01%
Not counted as selling: 137 mergers and delistings.
Opened and closed
New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.
Opened by the most managers
-
SGI Somnigroup International Inc. 7 managers avg 1.1% of book · Chris James - Meritage Group, Davidson Kempner Capital Management and 5 more
Opened by
- Chris James - Meritage Group opened 3.1% of book
- Davidson Kempner Capital Management opened 1.3% of book
- Dan Sundheim - D1 Capital Partners opened 1.2% of book
- Seth Klarman - Baupost Group opened 1.2% of book
- Farallon Capital Management opened 0.44% of book
- George Soros - Soros Fund Management opened 0.25% of book
- Senator Investment Group opened 0.02% of book
-
META Meta Platforms Inc. 6 managers avg 3.4% of book · Triple Frond Partners, Estuary Capital Management and 4 more
Opened by
- Triple Frond Partners opened 6.0% of book
- Estuary Capital Management opened 5.3% of book
- Gavin Baker - Atreides Management opened 4.2% of book
- Andreas Halvorsen - Viking Global Investors opened 2.7% of book
- Lee Ainslie - Maverick Capital opened 1.8% of book
- Glenview Capital Management opened 0.64% of book
-
TSM Taiwan Semiconductor Mfg Ltd 6 managers avg 2.6% of book · Ram Parameswaran - Octahedron Capital Management, Robert Karr - Joho Capital and 4 more
Opened by
- Ram Parameswaran - Octahedron Capital Management opened 6.6% of book
- Robert Karr - Joho Capital opened 4.8% of book
- Ryan Packard - Hiddenite Capital Partners opened 2.6% of book
- Mairs & Power opened 0.69% of book
- Duan Yongping - H&H International Investment opened 0.38% of book
- Davidson Kempner Capital Management opened 0.34% of book
-
NVDA Nvidia Corporation 6 managers avg 1.6% of book · Gavin Baker - Atreides Management, Estuary Capital Management and 4 more
Opened by
- Gavin Baker - Atreides Management opened 3.6% of book
- Estuary Capital Management opened 2.5% of book
- Dan Loeb - Third Point opened 2.4% of book
- Duan Yongping - H&H International Investment opened 0.58% of book
- Murphy Pohlad - Murphy Pohlad Asset Management opened 0.27% of book
- George Soros - Soros Fund Management opened 0.09% of book
-
APP Applovin Corp. 6 managers avg 1.3% of book · Nehal Chopra - Ratan Capital Management, Chase Coleman - Tiger Global Management and 4 more
Opened by
- Nehal Chopra - Ratan Capital Management opened 4.5% of book
- Chase Coleman - Tiger Global Management opened 1.7% of book
- Henry Ellenbogen - Durable Capital Partners opened 0.79% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.35% of book
- Davidson Kempner Capital Management opened 0.27% of book
- Christopher Davis - Davis Selected Advisers opened 0.25% of book
-
PRMB Primo Brands Corporation 6 managers avg 0.84% of book · Dan Sundheim - D1 Capital Partners, Lee Ainslie - Maverick Capital and 4 more
Opened by
- Dan Sundheim - D1 Capital Partners opened 2.8% of book
- Lee Ainslie - Maverick Capital opened 1.2% of book
- Andreas Halvorsen - Viking Global Investors opened 0.57% of book
- George Soros - Soros Fund Management opened 0.26% of book
- Davidson Kempner Capital Management opened 0.11% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.02% of book
-
ASML Asml Holding N V 4 managers avg 3.5% of book · Triple Frond Partners, Pat Dorsey - Dorsey Asset Management and 2 more
Opened by
- Triple Frond Partners opened 7.1% of book
- Pat Dorsey - Dorsey Asset Management opened 5.0% of book
- Rule One Partners opened 2.0% of book
- Ben Hoskin - Value Aligned Research Advisors opened <0.01% of book
-
AVGO Broadcom Inc. 4 managers avg 3.5% of book · Situational Awareness, Senator Investment Group and 2 more
Opened by
- Situational Awareness opened 11.7% of book
- Senator Investment Group opened 1.6% of book
- Davidson Kempner Capital Management opened 0.43% of book
- David Tepper - Appaloosa opened 0.26% of book
-
Intra-Cellular Therap… Intra-Cellular Therapies Inc. 4 managers avg 3.0% of book · Davidson Kempner Capital Management, Farallon Capital Management and 2 more
Opened by
- Davidson Kempner Capital Management opened 9.5% of book
- Farallon Capital Management opened 2.2% of book
- George Soros - Soros Fund Management opened 0.23% of book
- John Paulson - Paulson & Co. opened 0.16% of book
-
FLUT Flutter Entmt PLC 4 managers avg 2.5% of book · Ako Capital, Ben Jacobs - Anomaly Capital Management and 2 more
Opened by
- Ako Capital opened 7.4% of book
- Ben Jacobs - Anomaly Capital Management opened 1.9% of book
- Henry Ellenbogen - Durable Capital Partners opened 0.42% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 0.21% of book
Closed out by the most managers
-
GOOGL / GOOG Alphabet 8 managers was avg 1.7% of book · Brad Gerstner - Altimeter Capital Management, Ben Jacobs - Anomaly Capital Management and 6 more
Closed by
- Brad Gerstner - Altimeter Capital Management closed was 3.0%
- Ben Jacobs - Anomaly Capital Management closed was 2.9%
- Andreas Halvorsen - Viking Global Investors closed was 2.2%
- Glen Kacher - Light Street Capital Management closed was 2.1%
- Nehal Chopra - Ratan Capital Management closed was 1.8%
- Senator Investment Group closed was 0.70%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.39%
- John Paulson - Paulson & Co. closed was 0.12%
-
UNH Unitedhealth Group Inc. 6 managers was avg 2.4% of book · Abrams Bison - Abrams Bison Investments, Chris James - Meritage Group and 4 more
Closed by
- Abrams Bison - Abrams Bison Investments closed was 9.4%
- Chris James - Meritage Group closed was 3.6%
- Senator Investment Group closed was 1.1%
- Hillman Capital Management closed was 0.10%
- Francois Rochon - Giverny Capital closed was 0.04%
- Bill Nygren / Oakmark - Harris Associates L P closed was <0.01%
-
CRM Salesforce Inc. 6 managers was avg 1.7% of book · Alex Sacerdote - Whale Rock Capital Management, Glen Kacher - Light Street Capital Management and 4 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 3.3%
- Glen Kacher - Light Street Capital Management closed was 3.1%
- Brad Gerstner - Altimeter Capital Management closed was 1.6%
- Andreas Halvorsen - Viking Global Investors closed was 1.3%
- Lee Ainslie - Maverick Capital closed was 1.2%
- Corvex Management closed was 0.03%
-
TEAM Atlassian Corporation 6 managers was avg 1.2% of book · Henry Ellenbogen - Durable Capital Partners, Alex Sacerdote - Whale Rock Capital Management and 4 more
Closed by
- Henry Ellenbogen - Durable Capital Partners closed was 3.1%
- Alex Sacerdote - Whale Rock Capital Management closed was 2.0%
- Grant Wonders - Voyager Global Management closed was 0.97%
- Andreas Halvorsen - Viking Global Investors closed was 0.39%
- Chase Coleman - Tiger Global Management closed was 0.37%
- George Soros - Soros Fund Management closed was 0.32%
-
VST Vistra Corp. 5 managers was avg 1.3% of book · Harry Burn - Sound Shore Management, Dan Sundheim - D1 Capital Partners and 3 more
Closed by
- Harry Burn - Sound Shore Management closed was 2.2%
- Dan Sundheim - D1 Capital Partners closed was 1.5%
- Philippe Laffont - Coatue Management closed was 1.4%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.0%
- Andreas Halvorsen - Viking Global Investors closed was 0.27%
-
TSLA Tesla Inc. 5 managers was avg 1.2% of book · Dan Loeb - Third Point, Brad Gerstner - Altimeter Capital Management and 3 more
Closed by
- Dan Loeb - Third Point closed was 2.7%
- Brad Gerstner - Altimeter Capital Management closed was 2.6%
- Lee Ainslie - Maverick Capital closed was 0.64%
- David Katz - Matrix Asset Advisors closed was 0.04%
- Mairs & Power closed was <0.01%
-
AAPL Apple Inc. 5 managers was avg 0.40% of book · Alex Sacerdote - Whale Rock Capital Management, Davidson Kempner Capital Management and 3 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 1.7%
- Davidson Kempner Capital Management closed was 0.23%
- Arnold Van Den Berg - Van Den Berg Management I closed was 0.06%
- Ruane, Cunniff & Goldfarb closed was <0.01%
- Cathie Wood - Ark Investment Management closed was <0.01%
-
SPY Spdr S&P 500 ETF Tr 5 managers was avg 0.38% of book · Hillman Capital Management, Farallon Capital Management and 3 more
Closed by
- Hillman Capital Management closed was 1.4%
- Farallon Capital Management closed was 0.24%
- Vulcan Value Partners closed was 0.13%
- Samantha Mclemore - Patient Capital Management closed was 0.09%
- First Eagle Investment Management closed was 0.06%
-
WDAY Workday Inc. 4 managers was avg 1.7% of book · Stephen Mandel - Lone Pine Capital, Glen Kacher - Light Street Capital Management and 2 more
Closed by
- Stephen Mandel - Lone Pine Capital closed was 3.0%
- Glen Kacher - Light Street Capital Management closed was 2.1%
- Dan Loeb - Third Point closed was 1.7%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
-
FDX Fedex Corp. 4 managers was avg 1.6% of book · Ben Jacobs - Anomaly Capital Management, Harry Burn - Sound Shore Management and 2 more
Closed by
- Ben Jacobs - Anomaly Capital Management closed was 2.5%
- Harry Burn - Sound Shore Management closed was 2.2%
- David Tepper - Appaloosa closed was 1.5%
- Davidson Kempner Capital Management closed was 0.32%
Where the money went
Net bought by sector, with price moves taken out. Pick a sector to see its names.
- Energy 4.6% weight · +0.6 pts +$2.6B 17 bought · 15 sold
- Consumer Discretionary 15.3% weight · −0.2 pts +$2.5B 35 bought · 50 sold
- Health Care 12.5% weight · +0.5 pts +$2.4B 41 bought · 27 sold
- Information Technology 18.9% weight · −0.1 pts +$2B 37 bought · 46 sold
- Materials 3.0% weight · +0.1 pts +$1.5B 17 bought · 11 sold
- Real Estate 2.8% weight · no change +$349M 9 bought · 13 sold
- Consumer Staples 4.0% weight · no change +$58M 18 bought · 20 sold
- Industrials 9.9% weight · +0.1 pts −$645M 34 bought · 47 sold
- Utilities 1.9% weight · −0.1 pts −$1.1B 13 bought · 12 sold
- Communication Services 9.1% weight · −0.7 pts −$7.9B 23 bought · 55 sold
- Financials 17.9% weight · −0.1 pts −$10.4B 31 bought · 64 sold
Names without a sector (funds, foreign listings, private shares): −$881M.
Who moved the most
The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.
Biggest new bets
- Duan Yongping - H&H International Investment opened AAPL · Apple Inc. 63.3% of book
- Mohnish Pabrai - Dalal Street opened VAL · Valaris Ltd 23.9% of book
- Bill Ackman - Pershing Square opened UBER · Uber Technologies Inc. 18.5% of book
- Chris James - Meritage Group opened MSFT · Microsoft Corp. 14.3% of book
- Mala Gaonkar - Surgocap Partners opened BSX · Boston Scientific Corp. 13.2% of book
- Glenn Welling - Engaged Capital opened YETI · Yeti Hldgs Inc. 13.0% of book
Most active managers
- Ben Hoskin - Value Aligned Research Advisors 10 opened · 3 closed · +$962M net 275% of book traded
- Situational Awareness 6 opened · 2 closed · +$317M net 188% of book traded
- Dan Sundheim - D1 Capital Partners 17 opened · 12 closed · +$672M net 95% of book traded
- Duan Yongping - H&H International Investment 11 opened · 0 closed · +$12B net 83% of book traded
- Lee Ainslie - Maverick Capital 62 opened · 55 closed · +$350M net 71% of book traded
- Ram Parameswaran - Octahedron Capital Management 3 opened · 5 closed · +$11M net 70% of book traded
What they hold
Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, each manager counting once. Highest conviction is the average position among holders, three or more.
Most owned
- 1 GOOGL / GOOG Alphabet 65 managers −7
- 2 MSFT Microsoft Corp. 63 managers −1
- 3 AMZN Amazon Com Inc. 51 managers −1
- 4 META Meta Platforms Inc. 47 managers +4
- 5 TSM Taiwan Semiconductor Mfg Ltd 38 managers +4
- 6 BRK.B / BRK.A Berkshire Hathaway 37 managers +1
- 7 V Visa Inc. 34 managers −1
- 8 NVDA Nvidia Corporation 30 managers +4
- 9 AAPL Apple Inc. 29 managers −3
- 10 UNH Unitedhealth Group Inc. 29 managers −3
Largest
- 1 BRK.B / BRK.A Berkshire Hathaway 2.8% held by 37
- 2 GOOGL / GOOG Alphabet 2.7% held by 65
- 3 MSFT Microsoft Corp. 2.5% held by 63
- 4 AMZN Amazon Com Inc. 1.9% held by 51
- 5 META Meta Platforms Inc. 1.9% held by 47
- 6 CVNA Carvana Co. 1.8% held by 13
- 7 AAPL Apple Inc. 1.1% held by 29
- 8 V Visa Inc. 0.95% held by 34
- 9 TSM Taiwan Semiconductor Mfg Ltd 0.87% held by 38
- 10 MA Mastercard Inc. 0.76% held by 28
Highest conviction
- 1 CVNA Carvana Co. avg 19.2% held by 13
- 2 LOAR Loar Holdings Inc. avg 15.7% held by 3
- 3 TDG Transdigm Group Inc. avg 11.4% held by 6
- 4 BRK.B / BRK.A Berkshire Hathaway avg 10.4% held by 37
- 5 VAL Valaris Ltd avg 9.8% held by 3
- 6 SNX Td Synnex Corporation avg 8.7% held by 6
- 7 VFC Vf Corp. avg 7.7% held by 3
- 8 FICO Fair Isaac Corp. avg 7.6% held by 7
- 9 I3N Chart Inds Inc. avg 7.6% held by 4
- 10 EXEL Exelixis Inc. avg 7.5% held by 3
Did the combined book beat SPY?
Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.
Combined book, 8 quarters
+44.2%
SPY
+37.2%
Difference
+6.9 pts
2024 Q2, the start
+0.0% Combined book
+0.0% SPY
2024 Q3, since 2024 Q2
+7.5% Combined book
+5.4% SPY
That quarter: book +7.5%, SPY +5.4%
2024 Q4, since 2024 Q2
+10.2% Combined book
+7.7% SPY
That quarter: book +2.6%, SPY +2.1%
2025 Q1, since 2024 Q2
+6.0% Combined book
+2.8% SPY
That quarter: book −3.8%, SPY −4.6%
2025 Q2, since 2024 Q2
+18.3% Combined book
+13.5% SPY
That quarter: book +11.6%, SPY +10.5%
2025 Q3, since 2024 Q2
+29.0% Combined book
+22.4% SPY
That quarter: book +9.1%, SPY +7.8%
2025 Q4, since 2024 Q2
+31.8% Combined book
+25.3% SPY
That quarter: book +2.1%, SPY +2.4%
2026 Q1, since 2024 Q2
+25.9% Combined book
+19.5% SPY
That quarter: book −4.4%, SPY −4.6%
2026 Q2, since 2024 Q2
+44.2% Combined book
+37.2% SPY
That quarter: book +14.5%, SPY +14.8%
Quarter by quarter
| Quarter | Each manager once | By dollars | SPY | Book − SPY | Managers |
|---|---|---|---|---|---|
| 2026 Q2 | +14.5% | +11.5% | +14.8% | −0.4 pts | 133 |
| 2026 Q1 | −4.4% | −4.2% | −4.6% | +0.2 pts | 136 |
| 2025 Q4 | +2.1% | +2.6% | +2.4% | −0.2 pts | 136 |
| 2025 Q3 | +9.1% | +6.3% | +7.8% | +1.2 pts | 136 |
| 2025 Q2 | +11.6% | +8.0% | +10.5% | +1.1 pts | 136 |
| 2025 Q1 | −3.8% | −2.0% | −4.6% | +0.7 pts | 136 |
| 2024 Q4 | +2.6% | +1.1% | +2.1% | +0.4 pts | 134 |
| 2024 Q3 | +7.5% | +6.9% | +5.4% | +2.1 pts | 133 |
All 2,486 names
Download CSVShowing 300 of 356 matching names. The CSV has every name.
| Ticker | Company | Sector | Held by | Weight | Net bought | Bought / sold | Opened / closed |
|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group Inc. | Health Care | 29 −3 | 0.53% | −$33M | 7 / 14 | 3 / 6 |
| DHR | Danaher Corporation | Health Care | 18 +2 | 0.24% | −$63M | 7 / 8 | 4 / 2 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 15 −2 | 0.19% | −$312M | 3 / 9 | 0 / 2 |
| JNJ | Johnson & Johnson | Health Care | 15 | 0.16% | −$265M | 0 / 3 | 0 / 0 |
| ELV | Elevance Health Inc. | Health Care | 14 +1 | 0.38% | +$177M | 3 / 2 | 1 / 0 |
| LLY | Eli Lilly & Co. | Health Care | 14 −2 | 0.19% | +$341M | 6 / 5 | 0 / 2 |
| CVS | Cvs Health Corp. | Health Care | 13 | 0.45% | +$303M | 3 / 3 | 0 / 0 |
| PFE | Pfizer Inc. | Health Care | 13 +1 | 0.12% | −$184M | 4 / 3 | 1 / 0 |
| BMY | Bristol-Myers Squibb Co. | Health Care | 12 −1 | 0.14% | −$347M | 2 / 6 | 1 / 2 |
| MRK | Merck & Co. Inc. | Health Care | 12 −1 | 0.11% | +$136M | 2 / 3 | 0 / 1 |
| ABT | Abbott Labs | Health Care | 11 +1 | 0.07% | −$19M | 3 / 3 | 2 / 1 |
| ABBV | Abbvie Inc. | Health Care | 11 −3 | 0.03% | −$102M | 1 / 8 | 0 / 3 |
| HCA | Hca Healthcare Inc. | Health Care | 10 −1 | 0.22% | +$2M | 3 / 4 | 1 / 2 |
| CI | The Cigna Group | Health Care | 10 | 0.15% | −$74M | 1 / 1 | 0 / 0 |
| MDT | Medtronic PLC | Health Care | 10 +1 | 0.10% | −$10M | 2 / 3 | 1 / 0 |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | 10 | 0.10% | +$60M | 1 / 2 | 0 / 0 |
| BDX | Becton Dickinson & Co. | Health Care | 9 +1 | 0.12% | +$893M | 4 / 4 | 2 / 1 |
| BAX | Baxter International, Inc. | Health Care | 9 | 0.11% | +$173M | 3 / 3 | 0 / 0 |
| ZTS | Zoetis Inc. | Health Care | 9 | 0.11% | +$545M | 2 / 2 | 0 / 0 |
| GEHC | Ge Healthcare Technologies, Inc. | Health Care | 9 −2 | 0.04% | −$592M | 2 / 3 | 0 / 2 |
| BSX | Boston Scientific Corp. | Health Care | 8 | 0.17% | +$96M | 2 / 4 | 1 / 1 |
| TEVA | Teva Pharmaceutical Inds Ltd | Health Care | 8 −1 | 0.14% | +$261M | 7 / 3 | 1 / 2 |
| ILMN | Illumina Inc. | Health Care | 8 −1 | 0.12% | −$101M | 3 / 6 | 0 / 1 |
| AMGN | Amgen Inc. | Health Care | 8 −1 | 0.05% | −$3M | 0 / 4 | 0 / 1 |
| NTRA | Natera Inc. | Health Care | 7 | 0.21% | +$20M | 2 / 3 | 0 / 0 |
| THC | Tenet Healthcare Corp. | Health Care | 7 | 0.16% | +$93M | 4 / 3 | 0 / 0 |
| INSM | Insmed Inc. | Health Care | 7 | 0.15% | +$15M | 2 / 4 | 1 / 1 |
| WST | West Pharmaceutical Svsc Inc. | Health Care | 7 | 0.14% | +$298M | 2 / 2 | 1 / 1 |
| GSK | Gsk PLC | Health Care | 7 +1 | 0.14% | +$402M | 2 / 2 | 1 / 0 |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | 7 +2 | 0.06% | +$148M | 3 / 0 | 2 / 0 |
| ICLR | Icon PLC | Health Care | 7 −1 | 0.06% | +$67M | 4 / 3 | 1 / 2 |
| DGX | Quest Diagnostics Inc. | Health Care | 7 | 0.03% | −$34M | 1 / 3 | 0 / 0 |
| NVO | Novo-Nordisk A S | Health Care | 7 −1 | 0.02% | −$381M | 1 / 2 | 0 / 1 |
| SOLV | Solventum Corporation | Health Care | 6 | 0.16% | −$27M | 0 / 2 | 0 / 0 |
| MCK | Mckesson Corp. | Health Care | 6 +1 | 0.16% | −$263M | 2 / 4 | 2 / 1 |
| CAH | Cardinal Health Inc. | Health Care | 6 +1 | 0.11% | +$35M | 1 / 2 | 1 / 0 |
| SYK | Stryker Corporation | Health Care | 6 | 0.11% | −$190M | 0 / 3 | 0 / 0 |
| HUM | Humana, Inc. | Health Care | 6 −2 | 0.10% | +$129M | 2 / 3 | 0 / 2 |
| IDXX | Idexx Labs Inc. | Health Care | 6 +2 | 0.08% | +$195M | 2 / 1 | 2 / 0 |
| SNY | Sanofi SA | Health Care | 6 | 0.06% | −$120M | 3 / 1 | 1 / 1 |
| TECH | Bio Techne Corp. | Health Care | 6 +1 | 0.04% | +$4M | 3 / 2 | 1 / 0 |
| MEDP | Medpace Hldgs Inc. | Health Care | 6 +1 | 0.04% | +$79M | 4 / 0 | 1 / 0 |
| NVS | Novartis AG | Health Care | 6 | 0.02% | −$45M | 0 / 1 | 0 / 0 |
| ACHC | Acadia Healthcare Company In | Health Care | 5 | 0.13% | +$152M | 4 / 2 | 1 / 1 |
| OSCR | Oscar Health Inc. | Health Care | 5 | 0.13% | −$77M | 1 / 3 | 1 / 1 |
| BIIB | Biogen Inc. | Health Care | 5 −1 | 0.09% | +$13M | 3 / 1 | 0 / 1 |
| RPRX | Royalty Pharma PLC | Health Care | 5 +1 | 0.08% | −$40M | 2 / 1 | 1 / 0 |
| VTRS | Viatris Inc. | Health Care | 5 | 0.07% | +$15M | 0 / 1 | 0 / 0 |
| IQV | Iqvia Hldgs Inc. | Health Care | 5 −1 | 0.07% | +$7M | 1 / 2 | 0 / 1 |
| CNC | Centene Corp. Del | Health Care | 5 | 0.06% | −$332M | 1 / 3 | 1 / 1 |
| AVTR | Avantor, Inc. | Health Care | 5 −1 | 0.05% | −$73M | 1 / 4 | 0 / 1 |
| ALKS | Alkermes PLC | Health Care | 5 +1 | 0.05% | +$41M | 1 / 3 | 1 / 0 |
| BNTX | Biontech Se | Health Care | 5 | 0.04% | −$7M | 1 / 3 | 0 / 0 |
| VRTX | Vertex Pharmaceuticals | Health Care | 5 +1 | 0.04% | +$13M | 1 / 2 | 1 / 0 |
| NBIX | Neurocrine Biosciences, Inc. | Health Care | 5 +1 | 0.04% | +$269M | 3 / 1 | 1 / 0 |
| VEEV | Veeva Sys Inc. | Health Care | 5 | 0.03% | +$463M | 1 / 4 | 0 / 0 |
| COR | Cencora Inc. | Health Care | 5 +2 | 0.02% | +$308M | 2 / 1 | 2 / 0 |
| ALGN | Align Technology Inc. | Health Care | 5 −1 | 0.01% | −$120K | 1 / 3 | 0 / 1 |
| ISRG | Intuitive Surgical Inc. | Health Care | 5 −2 | 0.01% | −$175M | 0 / 4 | 0 / 2 |
| UTHR | United Therapeutics Corp. | Health Care | 4 +1 | 0.18% | −$26M | 1 / 2 | 1 / 0 |
| BMRN | Biomarin Pharmaceutical, Inc. | Health Care | 4 | 0.13% | +$30M | 0 / 1 | 0 / 0 |
| WAT | Waters Corp. | Health Care | 4 +1 | 0.08% | +$23M | 2 / 0 | 1 / 0 |
| UHS | Universal Hlth Svcs Inc. | Health Care | 4 +1 | 0.07% | +$14M | 1 / 0 | 1 / 0 |
| IONS | Ionis Pharmaceuticals Inc. | Health Care | 4 +1 | 0.06% | −$7M | 1 / 1 | 1 / 0 |
| BIO | Bio Rad Labs Inc. | Health Care | 4 | 0.06% | +$304M | 3 / 0 | 0 / 0 |
| A | Agilent Technologies Inc. | Health Care | 4 | 0.05% | −$15M | 0 / 1 | 0 / 0 |
| NVST | Envista Holdings Corporation | Health Care | 4 | 0.04% | +$13M | 1 / 1 | 0 / 0 |
| SNDX | Syndax Pharmaceuticals Inc. | Health Care | 4 | 0.04% | −$7M | 1 / 1 | 0 / 0 |
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | 4 +1 | 0.04% | −$50M | 1 / 2 | 1 / 0 |
| HOLX | Hologic, Inc. | Health Care | 4 | 0.03% | +$27M | 2 / 1 | 0 / 0 |
| BBIO | Bridgebio Pharma Inc. | Health Care | 4 +2 | 0.03% | −$35M | 3 / 1 | 2 / 0 |
| MTD | Mettler Toledo International | Health Care | 4 | 0.03% | −$450K | 1 / 0 | 0 / 0 |
| EW | Edwards Lifesciences Corp. | Health Care | 4 −4 | 0.03% | −$65M | 0 / 5 | 0 / 4 |
| HSIC | Henry Schein, Inc. | Health Care | 4 −1 | 0.03% | −$26M | 0 / 2 | 0 / 1 |
| BHVN | Biohaven Ltd | Health Care | 4 | 0.02% | +$7M | 1 / 2 | 0 / 0 |
| GILD | Gilead Sciences, Inc. | Health Care | 4 | 0.02% | −$42M | 2 / 2 | 1 / 1 |
| NAMS | Newamsterdam Pharma Company | Health Care | 4 −1 | 0.01% | +$2M | 2 / 2 | 0 / 1 |
| PGNY | Progyny Inc. | Health Care | 4 +1 | <0.01% | +$896K | 2 / 0 | 1 / 0 |
| EXEL | Exelixis Inc. | Health Care | 3 | 0.17% | −$48M | 1 / 1 | 0 / 0 |
| JAZZ | Jazz Pharmaceuticals PLC | Health Care | 3 | 0.13% | −$11M | 1 / 2 | 0 / 0 |
| NVAX | Novavax Inc. | Health Care | 3 +1 | 0.11% | +$24M | 1 / 0 | 1 / 0 |
| BHC | Bausch Health Companies Inc. | Health Care | 3 −1 | 0.10% | −$74K | 0 / 1 | 0 / 1 |
| OGN | Organon & Company | Health Care | 3 +1 | 0.09% | +$22M | 2 / 0 | 1 / 0 |
| RVMD | Revolution Medicines Inc. | Health Care | 3 | 0.08% | +$3M | 1 / 1 | 0 / 0 |
| ALC | Alcon AG | Health Care | 3 +2 | 0.08% | +$298M | 3 / 0 | 2 / 0 |
| BEAM | Beam Therapeutics Inc. | Health Care | 3 | 0.04% | +$74M | 3 / 1 | 1 / 1 |
| INSP | Inspire Med Sys Inc. | Health Care | 3 | 0.03% | +$81M | 3 / 0 | 0 / 0 |
| SHC | Sotera Health Co. | Health Care | 3 | 0.03% | +$2M | 1 / 0 | 0 / 0 |
| ASND | Ascendis Pharma A/S | Health Care | 3 | 0.03% | −$30M | 1 / 3 | 1 / 1 |
| ROIV | Roivant Sciences Ltd | Health Care | 3 | 0.03% | −$16M | 0 / 0 | 0 / 0 |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | 3 | 0.03% | −$8M | 0 / 1 | 0 / 0 |
| CRL | Charles Riv Labs Intl Inc. | Health Care | 3 −2 | 0.03% | −$185M | 0 / 4 | 0 / 2 |
| INCY | Incyte Corp. | Health Care | 3 −1 | 0.03% | +$7M | 1 / 1 | 0 / 1 |
| DXCM | Dexcom Inc. | Health Care | 3 | 0.03% | −$9M | 0 / 1 | 0 / 0 |
| EWTX | Edgewise Therapeutics Inc. | Health Care | 3 −1 | 0.02% | −$19M | 0 / 3 | 0 / 1 |
| LH | Labcorp Holdings Inc. | Health Care | 3 | 0.02% | −$27M | 0 / 3 | 0 / 0 |
| PBH | Prestige Consmr Healthcare I | Health Care | 3 | 0.02% | −$22M | 0 / 2 | 0 / 0 |
| GKOS | Glaukos Corp. | Health Care | 3 | 0.02% | −$3M | 0 / 1 | 0 / 0 |
| AXSM | Axsome Therapeutics Inc. | Health Care | 3 | 0.01% | −$13M | 0 / 1 | 0 / 0 |
| HQY | Healthequity Inc. | Health Care | 3 +1 | 0.01% | +$44M | 2 / 0 | 1 / 0 |
| URGN | Urogen Pharma Ltd | Health Care | 3 −1 | 0.01% | −$2M | 1 / 1 | 0 / 1 |
| DNA | Ginkgo Bioworks Holdings Inc. | Health Care | 3 | 0.01% | −$29K | 0 / 0 | 0 / 0 |
| STOK | Stoke Therapeutics Inc. | Health Care | 3 | 0.01% | +$4M | 2 / 0 | 0 / 0 |
| FMS | Fresenius Medical Care AG | Health Care | 3 +1 | 0.01% | +$3M | 1 / 0 | 1 / 0 |
| DYN | Dyne Therapeutics Inc. | Health Care | 3 | <0.01% | −$1M | 1 / 3 | 1 / 1 |
| IMVT | Immunovant Inc. | Health Care | 3 | <0.01% | −$4M | 1 / 1 | 0 / 0 |
| LXEO | Lexeo Therapeutics Inc. | Health Care | 3 | <0.01% | −$3M | 1 / 2 | 1 / 1 |
| XRAY | Dentsply Sirona Inc. | Health Care | 3 +1 | <0.01% | +$12M | 2 / 0 | 1 / 0 |
| ITGR | Integer Hldgs Corp. | Health Care | 3 +1 | <0.01% | +$21M | 2 / 0 | 1 / 0 |
| BTI | British Amern Tob PLC | Health Care | 3 | <0.01% | +$904K | 0 / 0 | 0 / 0 |
| BCYC | Bicycle Therapeutics Plc-Adr | Health Care | 3 | <0.01% | −$340K | 0 / 1 | 0 / 0 |
| CDNA | Caredx Inc. | Health Care | 3 | <0.01% | −$6M | 0 / 1 | 0 / 0 |
| NUVB | Nuvation Bio Inc. | Health Care | 3 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BBNX | Beta Bionics Inc. IPO or spin-off | Health Care | 3 +3 | <0.01% | +$41M | 3 / 0 | 3 / 0 |
| BKD | Brookdale Sr Living Inc. | Health Care | 3 | <0.01% | +$1M | 2 / 1 | 0 / 0 |
| Compugen | Compugen Ltd | Health Care | 3 +1 | <0.01% | +$1M | 1 / 1 | 1 / 0 |
| MDGL | Madrigal Pharmaceuticals Inc. | Health Care | 2 | 0.29% | +$19M | 1 / 0 | 0 / 0 |
| FOLD | Amicus Therapeutics Inc. | Health Care | 2 | 0.08% | −$3M | 0 / 1 | 0 / 0 |
| SUPN | Supernus Pharmaceuticals Inc. | Health Care | 2 +1 | 0.07% | +$14M | 1 / 0 | 1 / 0 |
| ACAD | Acadia Pharmaceuticals Inc. | Health Care | 2 +1 | 0.07% | +$1M | 1 / 1 | 1 / 0 |
| WGS | Genedx Holdings Corp. | Health Care | 2 | 0.06% | +$10M | 1 / 0 | 0 / 0 |
| LQDA | Liquidia Corporation | Health Care | 2 | 0.06% | +$19M | 2 / 0 | 0 / 0 |
| INDV | Indivior PLC | Health Care | 2 | 0.05% | +$24M | 2 / 0 | 0 / 0 |
| ENTA | Enanta Pharmaceuticals Inc. | Health Care | 2 | 0.05% | +$3M | 1 / 0 | 0 / 0 |
| CGON | Cg Oncology Inc. | Health Care | 2 +1 | 0.04% | +$1M | 1 / 1 | 1 / 0 |
| CYTK | Cytokinetics Inc. | Health Care | 2 | 0.03% | +$1M | 1 / 0 | 0 / 0 |
| ANAB | Anaptysbio Inc. | Health Care | 2 +1 | 0.03% | +$8M | 2 / 0 | 1 / 0 |
| IDYA | Ideaya Biosciences Inc. | Health Care | 2 | 0.03% | −$10M | 1 / 1 | 0 / 0 |
| AVAH | Aveanna Healthcare Hldgs Inc. | Health Care | 2 | 0.03% | +$798K | 1 / 0 | 0 / 0 |
| ARVN | Arvinas Inc. | Health Care | 2 | 0.03% | −$4M | 1 / 1 | 0 / 0 |
| AXGN | Axogen Inc. | Health Care | 2 | 0.03% | −$3M | 0 / 1 | 0 / 0 |
| LNTH | Lantheus Hldgs Inc. | Health Care | 2 | 0.03% | +$69M | 1 / 0 | 0 / 0 |
| CRSP | Crispr Therapeutics AG | Health Care | 2 | 0.03% | +$41M | 1 / 0 | 0 / 0 |
| NVCR | Novocure Ltd | Health Care | 2 | 0.03% | +$3M | 1 / 0 | 0 / 0 |
| Perrigo | Perrigo Company PLC | Health Care | 2 | 0.02% | +$20M | 2 / 0 | 0 / 0 |
| PTGX | Protagonist Therapeutics Inc. | Health Care | 2 | 0.02% | +$9M | 0 / 0 | 0 / 0 |
| AGIO | Agios Pharmaceuticals Inc. | Health Care | 2 +1 | 0.02% | +$9M | 1 / 0 | 1 / 0 |
| TWST | Twist Bioscience Corp. | Health Care | 2 | 0.02% | +$25M | 1 / 0 | 0 / 0 |
| MMSI | Merit Med Sys Inc. | Health Care | 2 +1 | 0.02% | +$135M | 1 / 0 | 1 / 0 |
| RARE | Ultragenyx Pharmaceutical In | Health Care | 2 −1 | 0.02% | −$3M | 0 / 2 | 0 / 1 |
| MOH | Molina Healthcare Inc. | Health Care | 2 +1 | 0.02% | +$366M | 2 / 0 | 1 / 0 |
| DVA | Davita Inc. | Health Care | 2 −1 | 0.02% | −$181M | 1 / 1 | 0 / 1 |
| IOVA | Iovance Biotherapeutics Inc. | Health Care | 2 | 0.01% | +$565K | 1 / 0 | 0 / 0 |
| FTRE | Fortrea Hldgs Inc. | Health Care | 2 | 0.01% | −$9M | 1 / 1 | 0 / 0 |
| VNDA | Vanda Pharmaceuticals Inc. | Health Care | 2 | 0.01% | +$3M | 1 / 0 | 0 / 0 |
| Masimo | Masimo Corp. | Health Care | 2 −1 | 0.01% | +$123M | 1 / 2 | 1 / 2 |
| CNTA | Centessa Pharmaceuticals PLC | Health Care | 2 −1 | 0.01% | +$2M | 1 / 2 | 0 / 1 |
| DOCS | Doximity Inc. | Health Care | 2 | 0.01% | −$133M | 2 / 1 | 1 / 1 |
| LKFT | Galapagos NV | Health Care | 2 | 0.01% | +$85K | 0 / 0 | 0 / 0 |
| PVLA | Palvella Therapeutics Inc. | Health Care | 2 +1 | 0.01% | +$4M | 1 / 1 | 1 / 0 |
| ADPT | Adaptive Biotechnologies Cor | Health Care | 2 | <0.01% | −$13M | 0 / 1 | 0 / 0 |
| VCYT | Veracyte Inc. | Health Care | 2 | <0.01% | −$8M | 0 / 1 | 0 / 0 |
| TRVI | Trevi Therapeutics Inc. | Health Care | 2 | <0.01% | −$17M | 0 / 2 | 0 / 0 |
| LRMR | Larimar Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| PCVX | Vaxcyte Inc. | Health Care | 2 −2 | <0.01% | −$6M | 1 / 3 | 1 / 3 |
| BRKR | Bruker Corp. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| MIRM | Mirum Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$28M | 0 / 1 | 0 / 0 |
| BLCO | Bausch Plus Lomb Corp. | Health Care | 2 | <0.01% | −$9M | 1 / 1 | 1 / 1 |
| PHG | Koninklijke Philips NV | Health Care | 2 | <0.01% | −$838K | 1 / 0 | 0 / 0 |
| SDGR | Schrodinger Inc. | Health Care | 2 | <0.01% | +$2M | 0 / 0 | 0 / 0 |
| RCKT | Rocket Pharmaceuticals Inc. | Health Care | 2 −2 | <0.01% | −$8M | 0 / 2 | 0 / 2 |
| BFLY | Butterfly Network Inc. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| QURE | Uniqure NV | Health Care | 2 +1 | <0.01% | +$1M | 2 / 0 | 1 / 0 |
| CMPS | Compass Pathways PLC | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| WAY | Waystar Hldg Corp. | Health Care | 2 | <0.01% | +$27M | 2 / 0 | 0 / 0 |
| TSHA | Taysha Gene Therapies Inc. | Health Care | 2 | <0.01% | +$845K | 1 / 0 | 0 / 0 |
| ALLO | Allogene Therapeutics Inc. | Health Care | 2 | <0.01% | +$204K | 1 / 0 | 0 / 0 |
| CAPR | Capricor Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| TVTX | Travere Therapeutics Inc. | Health Care | 2 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| ORIC | Oric Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$6M | 2 / 1 | 1 / 1 |
| ELAN | Elanco Animal Health, Inc. | Health Care | 2 | <0.01% | −$3M | 0 / 0 | 0 / 0 |
| NRIX | Nurix Therapeutics Inc. | Health Care | 2 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| VKTX | Viking Therapeutics Inc. | Health Care | 2 | <0.01% | +$404K | 0 / 0 | 0 / 0 |
| BWAY | Brainsway Ltd | Health Care | 2 | <0.01% | −$227K | 1 / 1 | 0 / 0 |
| EHC | Encompass Health Corp. | Health Care | 2 | <0.01% | +$15M | 1 / 1 | 0 / 0 |
| COO | Cooper Cos Inc. | Health Care | 2 −2 | <0.01% | −$191M | 0 / 2 | 0 / 2 |
| EMBC | Embecta Corp. | Health Care | 2 | <0.01% | −$149K | 0 / 0 | 0 / 0 |
| ALVO | Alvotech SA | Health Care | 2 | <0.01% | −$553K | 0 / 0 | 0 / 0 |
| NEOG | Neogen Corp. | Health Care | 2 | <0.01% | −$8M | 0 / 1 | 0 / 0 |
| SRTA | Blade Air Mobility Inc. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| PEPG | Pepgen Inc. | Health Care | 2 | <0.01% | +$436K | 1 / 0 | 0 / 0 |
| IVVD | Invivyd Inc. | Health Care | 2 | <0.01% | −$489K | 0 / 1 | 0 / 0 |
| RDNT | Radnet Inc. | Health Care | 2 | <0.01% | +$32M | 1 / 1 | 0 / 0 |
| ENOV | Enovis Corporation | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| TMDX | Transmedics Group Inc. | Health Care | 2 +1 | <0.01% | −$8M | 2 / 1 | 2 / 1 |
| RGEN | Repligen Corp. | Health Care | 2 | <0.01% | +$4M | 1 / 1 | 0 / 0 |
| PRME | Prime Medicine Inc. | Health Care | 2 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| GRFS | Grifols S A | Health Care | 2 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| DCGO | Docgo Inc. | Health Care | 2 | <0.01% | +$908K | 1 / 0 | 0 / 0 |
| LIVN | Livanova PLC | Health Care | 2 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| HROW | Harrow Health Inc. | Health Care | 1 | 0.17% | −$931K | 0 / 0 | 0 / 0 |
| SGRY | Surgery Partners Inc. | Health Care | 1 −2 | 0.10% | +$33M | 1 / 2 | 0 / 2 |
| LFCR | Lifecore Biomedical Inc. | Health Care | 1 | 0.08% | $0 | 0 / 0 | 0 / 0 |
| ETON | Eton Pharmaceuticals Inc. | Health Care | 1 | 0.06% | $0 | 0 / 0 | 0 / 0 |
| SNWV | Sanuwave Health Inc. IPO or spin-off | Health Care | 1 +1 | 0.06% | +$34M | 1 / 0 | 1 / 0 |
| STXS | Stereotaxis Inc. | Health Care | 1 | 0.05% | $0 | 0 / 0 | 0 / 0 |
| DNTH | Dianthus Therapeutics Inc. | Health Care | 1 | 0.04% | −$21M | 0 / 1 | 0 / 0 |
| RYTM | Rhythm Pharmaceuticals Inc. | Health Care | 1 | 0.04% | −$530K | 0 / 0 | 0 / 0 |
| ATRC | Atricure Inc. | Health Care | 1 | 0.04% | −$2M | 0 / 1 | 0 / 0 |
| TGTX | Tg Therapeutics Inc. | Health Care | 1 | 0.03% | −$68M | 0 / 1 | 0 / 0 |
| PRTA | Prothena Corp. PLC | Health Care | 1 | 0.03% | −$968K | 0 / 0 | 0 / 0 |
| Bausch Lomb | Bausch Lomb Corp. | Health Care | 1 | 0.03% | $0 | 0 / 0 | 0 / 0 |
| OCUL | Ocular Therapeutix Inc. | Health Care | 1 | 0.02% | −$20M | 0 / 1 | 0 / 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. | Health Care | 1 | 0.02% | −$685K | 0 / 1 | 0 / 0 |
| PRVA | Privia Health Group Inc. | Health Care | 1 −1 | 0.02% | −$16M | 0 / 1 | 0 / 1 |
| RXRX | Recursion Pharmaceuticals Inc. | Health Care | 1 | 0.01% | +$13M | 1 / 0 | 0 / 0 |
| TNDM | Tandem Diabetes Care Inc. | Health Care | 1 | 0.01% | +$1M | 1 / 0 | 0 / 0 |
| MLYS | Mineralys Therapeutics Inc. | Health Care | 1 | 0.01% | +$3M | 1 / 0 | 0 / 0 |
| RCUS | Arcus Biosciences Inc. | Health Care | 1 | 0.01% | +$3M | 1 / 0 | 0 / 0 |
| PGEN | Precigen Inc. | Health Care | 1 | <0.01% | −$758K | 0 / 0 | 0 / 0 |
| ANIK | Anika Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$6M | 1 / 0 | 1 / 0 |
| HIMS | Hims & Hers Health Inc. | Health Care | 1 | <0.01% | −$13M | 0 / 1 | 0 / 0 |
| COLL | Collegium Pharmaceutical Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BCRX | Biocryst Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$816K | 0 / 1 | 0 / 0 |
| WVE | Wave Life Sciences Ltd | Health Care | 1 −1 | <0.01% | −$683K | 0 / 1 | 0 / 1 |
| XOMA | Xoma Corp. Del | Health Care | 1 | <0.01% | +$61K | 0 / 0 | 0 / 0 |
| OPCH | Option Care Health Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$123M | 1 / 0 | 1 / 0 |
| LZAGY | Lonza Group Adr | Health Care | 1 | <0.01% | −$173K | 0 / 0 | 0 / 0 |
| Enhabit | Enhabit Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PHAT | Phathom Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| IRON | Disc Medicine Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| INGN | Inogen Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| CATX | Perspective Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$1M | 0 / 2 | 0 / 1 |
| PODD | Insulet Corp. | Health Care | 1 | <0.01% | −$131K | 0 / 0 | 0 / 0 |
| CNTX | Context Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| KURA | Kura Oncology Inc. | Health Care | 1 | <0.01% | +$99K | 0 / 0 | 0 / 0 |
| CRNX | Crinetics Pharmaceuticals In | Health Care | 1 −1 | <0.01% | +$14M | 1 / 1 | 0 / 1 |
| MYGN | Myriad Genetics Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| RCEL | Avita Medical Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| BCAX | Bicara Therapeutics Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| ZNTL | Zentalis Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$346K | 1 / 0 | 0 / 0 |
| ORKA | Oruka Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARAY | Accuray Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| GH | Guardant Health Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 0 | 0 / 0 |
| ALHC | Alignment Healthcare Inc. | Health Care | 1 | <0.01% | −$19M | 0 / 1 | 0 / 0 |
| PRQR | Proqr Therapeutics N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| COYA | Coya Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| HALO | Halozyme Therapeutics | Health Care | 1 | <0.01% | −$14K | 0 / 0 | 0 / 0 |
| TELA | Tela Bio Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DNLI | Denali Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| MBX | Mbx Biosciences Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| IART | Integra Lifesciences Hldgs | Health Care | 1 | <0.01% | −$770K | 0 / 1 | 0 / 0 |
| ARGX | Argenx Se | Health Care | 1 | <0.01% | −$17M | 0 / 1 | 0 / 0 |
| SNN | Smith & Nephew PLC | Health Care | 1 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| IRD | Opus Genetics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| SPRY | Ars Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$82K | 1 / 0 | 0 / 0 |
| IBIO | Ibio Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ALEC | Alector Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| FHTX | Foghorn Therapeutics Inc. | Health Care | 1 | <0.01% | +$431K | 1 / 0 | 0 / 0 |
| RZLT | Rezolute Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| GPCR | Structure Therapeutics Inc. | Health Care | 1 | <0.01% | +$407K | 1 / 0 | 0 / 0 |
| CERS | Cerus Corp. | Health Care | 1 | <0.01% | −$222K | 0 / 0 | 0 / 0 |
| ABSI | Absci Corp. | Health Care | 1 | <0.01% | +$7M | 1 / 0 | 0 / 0 |
| AUTL | Autolus Therapeutics PLC | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PSNL | Personalis Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| ALDX | Aldeyra Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DMAC | Diamedica Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$52M | 1 / 0 | 1 / 0 |
| IPSC | Century Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ACRS | Aclaris Therapeutics Inc. | Health Care | 1 | <0.01% | +$315K | 1 / 0 | 0 / 0 |
| ARCT | Arcturus Therapeutics Holdings | Health Care | 1 | <0.01% | +$790K | 0 / 0 | 0 / 0 |
| ZLAB | Zai Lab Ltd | Health Care | 1 | <0.01% | −$3M | 0 / 0 | 0 / 0 |
| PYXS | Pyxis Oncology Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PHVS | Pharvaris N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| EOLS | Evolus Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| NGNE | Neurogene Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CRDF | Cardiff Oncology Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$471K | 1 / 0 | 1 / 0 |
| ERAS | Erasca Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$466K | 1 / 0 | 1 / 0 |
| IFRX | Inflarx NV IPO or spin-off | Health Care | 1 +1 | <0.01% | +$459K | 1 / 0 | 1 / 0 |
| OSUR | Orasure Technologies Inc. | Health Care | 1 −1 | <0.01% | −$9K | 1 / 1 | 0 / 1 |
| AQST | Aquestive Therapeutics Inc. | Health Care | 1 | <0.01% | +$44K | 1 / 0 | 0 / 0 |
| USNA | Usana Health Sciences Inc. | Health Care | 1 | <0.01% | +$219K | 0 / 0 | 0 / 0 |
| CRMD | Cormedix Inc. | Health Care | 1 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| ABEO | Abeona Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| SION | Sionna Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$31M | 1 / 0 | 1 / 0 |
| KPTI | Karyopharm Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$503K | 1 / 0 | 1 / 0 |
| DERM | Journey Medical Corp. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$409K | 1 / 0 | 1 / 0 |
| ADCT | Adc Therapeutics SA | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ESTA | Establishment Labs Hldgs Inc. | Health Care | 1 | <0.01% | −$249K | 0 / 0 | 0 / 0 |
| GUTS | Fractyl Health Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| TECX | Tectonic Therapeutic Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| INBX | Inhibrx Biosciences Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| APRE | Aprea Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BDTX | Black Diamond Therapeutics I | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RFL | Rafael Holding | Health Care | 1 | <0.01% | −$10K | 0 / 0 | 0 / 0 |
| NUVL | Nuvalent Inc. | Health Care | 1 −1 | <0.01% | −$4M | 0 / 1 | 0 / 1 |
| TYRA | Tyra Biosciences Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| GANX | Gain Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| VYGR | Voyager Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RMD | Resmed | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ELVN | Enliven Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$222K | 1 / 0 | 1 / 0 |
| RDY | Dr Reddy's Laboratories Ltd | Health Care | 1 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| TNGX | Tango Therapeutics Inc. | Health Care | 1 | <0.01% | +$837K | 1 / 0 | 0 / 0 |
| GMED | Globus Med Inc. | Health Care | 1 | <0.01% | +$6M | 1 / 0 | 0 / 0 |
| SYRE | Spyre Therapeutics Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| HSTM | Healthstream Inc. | Health Care | 1 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| RLMD | Relmada Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PNTG | Pennant Group Inc. | Health Care | 1 | <0.01% | +$415K | 0 / 0 | 0 / 0 |
| AORT | Artivion Inc. | Health Care | 1 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| FTLF | Fitlife Brands Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
How the numbers work
Same managers in both quarters
Changes compare only managers with a 13F in both 2024 Q4 and 2025 Q1: 136 this time.
Buying versus price
Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.
Who counts as a buyer or a seller
A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.
IPOs, spin-offs and mergers
A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.
Each manager once, or by dollars
By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.
Sectors
GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.
The combined book against SPY
Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.
What a 13F leaves out
Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.